Form 8-K - Current report:
SEC Accession No. 0001437749-17-013264
Filing Date
2017-07-28
Accepted
2017-07-28 12:47:08
Documents
2
Period of Report
2017-07-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K atrn20170726b_8k.htm 8-K 35546
2 EXHIBIT 3.1 ex3-1.htm EX-3.1 124431
  Complete submission text file 0001437749-17-013264.txt   161419
Mailing Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010
Business Address 149 FIFTH AVENUE SUITE 500 NEW YORK NY 10010 (212) 994-8200
Protagenic Therapeutics, Inc.\new (Filer) CIK: 0001022899 (see all company filings)

EIN.: 061390025 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51353 | Film No.: 17988962
SIC: 7389 Services-Business Services, NEC